Autopsy report · NCT02840110
Long-Term Follow-Up Study of Subjects Treated With ACTR T Cell Product
Cause of deathFunding or business
“Business Decision”
Life of this trial
- Registered 3 months before it started.
- Ran for about 4 years 4 months before it stopped.
- 22 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- Cogent Biosciences, Inc.
- Sponsor type
- Industry
- Conditions
- B Cell Lymphomas; Multiple Myeloma; Solid Tumor; HER-2 Protein Overexpression
- Interventions
- ACTR T Cell Product
- Participants
- 22
- Sites
- 16
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.